AbstractClostridium difficile infection is a leading cause of antibiotic-related and healthcare-related diarrhoea. In the past decade, faecal microbiota transplantation or transfer has attracted increasing interest as an effective treatment strategy for severe recurrent C. difficile infection, with a global success rate of >80%. However, experience with this procedure is limited by a lack of randomized trials supporting its efficacy and the lack of standardization of the procedure. This review will address the practical aspects of the protocol
Background The Netherlands Donor Feces Bank provides standardized ready-to-use donor faecal suspensi...
Interest in the therapeutic potential of faecal microbiota transplant (FMT) has been increasing glob...
Background. Patients with recurrent Clostridium difficile infections (CDIs) constitute an increasing...
Clostridium difficile infection is a leading cause of antibiotic-related and healthcare-related diar...
ABSTRACT Clostridium difficile infection is a common complication following intestinal dysbiosis cau...
AbstractRecurrent Clostridium difficile infections constitute an important medical concern. Evidence...
Clostridium difficile infection (CDI) remains a major healthcare burden despite recent global falls ...
Background: Faecal microbiota transplantation or transfer (FMT) aims at replacing or reinforcing the...
Faecal microbiota transplantation is effective for treating recurrent forms of Clostridium difficile...
Background and aims: Clostridium difficile infection (CDI) constitutes an important cause of antibio...
BACKGROUND: Faecal microbiota transplantation or transfer (FMT) aims at replacing or reinforcing the...
By systematic review, we assessed the impact of fecal microbiota transplantation (FMT) for the treat...
Background: Faecal microbiota transplantation or transfer (FMT) aims at replacing or reinforcing the...
Faecal microbiota transplantation (FMT) is an important therapeutic option for Clostridium difficile...
ObjectivesAlthough systematic evaluation has confirmed the efficacy of fresh fecal microbiota transp...
Background The Netherlands Donor Feces Bank provides standardized ready-to-use donor faecal suspensi...
Interest in the therapeutic potential of faecal microbiota transplant (FMT) has been increasing glob...
Background. Patients with recurrent Clostridium difficile infections (CDIs) constitute an increasing...
Clostridium difficile infection is a leading cause of antibiotic-related and healthcare-related diar...
ABSTRACT Clostridium difficile infection is a common complication following intestinal dysbiosis cau...
AbstractRecurrent Clostridium difficile infections constitute an important medical concern. Evidence...
Clostridium difficile infection (CDI) remains a major healthcare burden despite recent global falls ...
Background: Faecal microbiota transplantation or transfer (FMT) aims at replacing or reinforcing the...
Faecal microbiota transplantation is effective for treating recurrent forms of Clostridium difficile...
Background and aims: Clostridium difficile infection (CDI) constitutes an important cause of antibio...
BACKGROUND: Faecal microbiota transplantation or transfer (FMT) aims at replacing or reinforcing the...
By systematic review, we assessed the impact of fecal microbiota transplantation (FMT) for the treat...
Background: Faecal microbiota transplantation or transfer (FMT) aims at replacing or reinforcing the...
Faecal microbiota transplantation (FMT) is an important therapeutic option for Clostridium difficile...
ObjectivesAlthough systematic evaluation has confirmed the efficacy of fresh fecal microbiota transp...
Background The Netherlands Donor Feces Bank provides standardized ready-to-use donor faecal suspensi...
Interest in the therapeutic potential of faecal microbiota transplant (FMT) has been increasing glob...
Background. Patients with recurrent Clostridium difficile infections (CDIs) constitute an increasing...